Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition

Journal of Cell Science

Volumn 127, Issue 1, 2014, Pages 85-100

  Lin, Yuh Charn ^a,b   Lee, Yi Ching ^c,d   Li, Ling Hui ^b   Cheng, Chien Jui ^e   Yang, Ruey Bing ^a,b,f  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^d INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Breast cancer; DNA hypermethylation; DNA methyltransferase; Epigenetic regulation; Epithelial mesenchymal transition; Tumor suppressor

Indexed keywords

BETA CATENIN; DNA METHYLTRANSFERASE 1; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; SIGNAL PEPTIDE-CUB EGF DOMAIN-CONTAINING PROTEIN 2; TRANSCRIPTION FACTOR SOX; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL JUNCTION; CELL MIGRATION; CELL MOTILITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; EXON; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR INVASION;

BREAST CANCER; DNA HYPERMETHYLATION; DNA METHYLTRANSFERASE; EPIGENETIC REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR SUPPRESSOR;

ADHERENS JUNCTIONS; BETA CATENIN; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; LUCIFERASES; MEMBRANE PROTEINS; SIGNAL TRANSDUCTION; SOX TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84891475269     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.132779     Document Type: Article

References (49)

1. Badve, S., Turbin, D., Thorat, M. A., Morimiya, A., Nielsen, T. O., Perou, C. M., Dunn, S., Huntsman, D. G. and Nakshatri, H. (2007). FOXA1 expression in breast cancer-correlation with luminal subtype A and survival. Clin. Cancer Res. 13, 4415-4421.
2. Berx, G. and Van Roy, F. (2001). The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res. 3, 289-293.
3. Carroll, J. S., Liu, X. S., Brodsky, A. S., Li, W., Meyer, C. A., Szary, A. J., Eeckhoute, J., Shao, W., Hestermann, E. V., Geistlinger, T. R. et al. (2005). Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122, 33-43.
4. Cheng, C. J., Lin, Y. C., Tsai, M. T., Chen, C. S., Hsieh, M. C., Chen, C. L. and Yang, R. B. (2009). SCUBE2 suppresses breast tumor cell proliferation and confers a favorable prognosis in invasive breast cancer. Cancer Res. 69, 3634-3641.
5. Cirillo, L. A., Lin, F. R., Cuesta, I., Friedman, D., Jarnik, M. and Zaret, K. S. (2002). Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell 9, 279-289.
6. Cowin, P., Rowlands, T. M. and Hatsell, S. J. (2005). Cadherins and catenins in breast cancer. Curr. Opin. Cell Biol. 17, 499-508.
7. Dong, C., Wu, Y., Yao, J., Wang, Y., Yu, Y., Rychahou, P. G., Evers, B. M. and Zhou, B. P. (2012). G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. J. Clin. Invest. 122, 1469-1486.
8. Fan, C., Oh, D. S., Wessels, L., Weigelt, B., Nuyten, D. S., Nobel, A. B., van't Veer, L. J. and Perou, C. M. (2006). Concordance among gene-expressionbased predictors for breast cancer. N. Engl. J. Med. 355, 560-569.
9. Fuxe, J., Vincent, T. and Garcia de Herreros, A. (2010). Transcriptional crosstalk between TGF-b and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle 9, 2363-2374.
10. Grady, W. M., Willis, J., Guilford, P. J., Dunbier, A. K., Toro, T. T., Lynch, H., Wiesner, G., Ferguson, K., Eng, C., Park, J. G. et al. (2000). Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat. Genet. 26, 16-17.
11. Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. E. and Baylin, S. B. (1995). Ecadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 55, 5195-5199.
12. Grimmond, S., Larder, R., Van Hateren, N., Siggers, P., Hulsebos, T. J., Arkell, R. and Greenfield, A. (2000). Cloning, mapping, and expression analysis of a gene encoding a novel mammalian EGF-related protein (SCUBE1). Genomics 70, 74-81.
13. Grimmond, S., Larder, R., Van Hateren, N., Siggers, P., Morse, S., Hacker, T., Arkell, R. and Greenfield, A. (2001). Expression of a novel mammalian epidermal growth factor-related gene during mouse neural development. Mech. Dev. 102, 209-211.
14. Hisamatsu, Y., Tokunaga, E., Yamashita, N., Akiyoshi, S., Okada, S., Nakashima, Y., Aishima, S., Morita, M., Kakeji, Y. and Maehara, Y. (2012). Impact of FOXA1 expression on the prognosis of patients with hormone receptor-positive breast cancer. Ann. Surg. Oncol. 19, 1145-1152.
15. Hollway, G. E., Maule, J., Gautier, P., Evans, T. M., Keenan, D. G., Lohs, C., Fischer, D., Wicking, C. and Currie, P. D. (2006). Scube2 mediates Hedgehog signalling in the zebrafish embryo. Dev. Biol. 294, 104-118.
16. Kawakami, A., Nojima, Y., Toyoda, A., Takahoko, M., Satoh, M., Tanaka, H., Wada, H., Masai, I., Terasaki, H., Sakaki, Y. et al. (2005). The zebrafishsecreted matrix protein you/scube2 is implicated in long-range regulation of hedgehog signaling. Curr. Biol. 15, 480-488.
17. Kim, C. and Paik, S. (2010). Gene-expression-based prognostic assays for breast cancer. Nat. Rev. Clin Oncol 7, 340-347.
18. Kim, S. K., Jang, H. R., Kim, J. H., Kim, M., Noh, S. M., Song, K. S., Kang, G.H., Kim, H. J., Kim, S. Y., Yoo, H. S. et al. (2008). CpG methylation in exon 1 of transcription factor 4 increases with age in normal gastric mucosa and is associated with gene silencing in intestinal-type gastric cancers. Carcinogenesis 29, 1623-1631.
19. Koizume, S., Tachibana, K., Sekiya, T., Hirohashi, S. and Shiraishi, M. (2002). Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells. Nucleic Acids Res. 30, 4770-4780.
20. Kormish, J. D., Sinner, D. and Zorn, A. M. (2010). Interactions between SOX factors and Wnt/beta-catenin signaling in development and disease. Dev. Dyn. 239, 56-68.
21. Lin, Y. C., Chen, C. C., Cheng, C. J. and Yang, R. B. (2011). Domain and functional analysis of a novel breast tumor suppressor protein, SCUBE2. J. Biol. Chem. 286, 27039-27047.
22. Liu, Y. N., Lee, W. W., Wang, C. Y., Chao, T. H., Chen, Y. and Chen, J. H. (2005). Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene 24, 8277-8290.
23. Lu, A., Gupta, A., Li, C., Ahlborn, T. E., Ma, Y., Shi, E. Y. and Liu, J. (2001). Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences. Oncogene 20, 5173-5185.
24. Mareel, M. M., Behrens, J., Birchmeier, W., De Bruyne, G. K., Vleminckx, K., Hoogewijs, A., Fiers, W. C. and Van Roy, F. M. (1991). Down-regulation of Ecadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice. Int. J. Cancer 47, 922-928.
25. Medvedeva, Y. A., Fridman, M. V., Oparina, N. J., Malko, D. B., Ermakova, E. O., Kulakovskiy, I. V., Heinzel, A. and Makeev, V. J. (2010). Intergenic, gene terminal, and intragenic CpG islands in the human genome. BMC Genomics 11, 48.
26. Osada, T., Sakamoto, M., Ino, Y., Iwamatsu, A., Matsuno, Y., Muto, T. and Hirohashi, S. (1996). E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. Hepatology 24, 1460-1467.
27. Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T. et al. (2004). A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 351, 2817-2826.
28. Paik, S., Tang, G., Shak, S., Kim, C., Baker, J., Kim, W., Cronin, M., Baehner, F. L., Watson, D., Bryant, J. et al. (2006). Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J. Clin. Oncol. 24, 3726-3734.
29. Perl, A. K., Wilgenbus, P., Dahl, U., Semb, H. and Christofori, G. (1998). A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392, 190-193.
30. Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A. et al. (2000). Molecular portraits of human breast tumours. Nature 406, 747-752.
31. Sinner, D., Rankin, S., Lee, M. and Zorn, A. M. (2004). Sox17 and beta-catenin cooperate to regulate the transcription of endodermal genes. Development 131, 3069-3080.
32. Sinner, D., Kordich, J. J., Spence, J. R., Opoka, R., Rankin, S., Lin, S. C., Jonatan, D., Zorn, A. M. and Wells, J. M. (2007). Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol. Cell. Biol. 27, 7802-7815.
33. Song, Y., Washington, M. K. and Crawford, H. C. (2010). Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer. Cancer Res. 70, 2115-2125.
34. Sparano, J. A. and Paik, S. (2008). Development of the 21-gene assay and its application in clinical practice and clinical trials. J. Clin. Oncol. 26, 721-728.
35. Strumane, K., Berx, G. and Van Roy, F. (2004). Cadherins in cancer. Handb Exp Pharmacol 165, 69-103.
36. Suzuki, M., Sunaga, N., Shames, D. S., Toyooka, S., Gazdar, A. F. and Minna, J. D. (2004). RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells. Cancer Res. 64, 3137-3143.
37. Takash, W., Cañ izares, J., Bonneaud, N., Poulat, F., Matté i, M. G., Jay, P. and Berta, P. (2001). SOX7 transcription factor: sequence, chromosomal localisation, expression, transactivation and interference with Wnt signalling. Nucleic Acids Res. 29, 4274-4283.
38. Tsai, M. T., Cheng, C. J., Lin, Y. C., Chen, C. C., Wu, A. R., Wu, M. T., Hsu, C. C. and Yang, R. B. (2009). Isolation and characterization of a secreted, cellsurface glycoprotein SCUBE2 from humans. Biochem. J. 422, 119-128.
39. van de Vijver, M. J., He, Y. D., van't Veer, L. J., Dai, H., Hart, A. A., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J. et al. (2002). A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999-2009.
40. van Roy, F. and Berx, G. (2008). The cell-cell adhesion molecule E-cadherin. Cell. Mol. Life Sci. 65, 3756-3788.
41. van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T. et al. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536.
42. Vleminckx, K., Vakaet, L., Jr, Mareel, M., Fiers, W. and van Roy, F. (1991). Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66, 107-119.
43. Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J. et al. (2005). Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365, 671-679.
44. Wang, G., Hu, X., Lu, C., Su, C., Luo, S. and Luo, Z. W. (2008). Promoterhypermethylation associated defective expression of E-cadherin in primary nonsmall cell lung cancer. Lung Cancer 62, 162-172.
45. Woods, I. G. and Talbot, W. S. (2005). The you gene encodes an EGF-CUB protein essential for Hedgehog signaling in zebrafish. PLoS Biol. 3, e66.
46. Wu, B. T., Su, Y. H., Tsai, M. T., Wasserman, S. M., Topper, J. N. and Yang, R. B. (2004). A novel secreted, cell-surface glycoprotein containing multiple epidermal growth factor-like repeats and one CUB domain is highly expressed in primary osteoblasts and bones. J. Biol. Chem. 279, 37485-37490.
47. Yang, R. B., Ng, C. K., Wasserman, S. M., Colman, S. D., Shenoy, S., Mehraban, F., Komuves, L. G., Tomlinson, J. E. and Topper, J. N. (2002). Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. J. Biol. Chem. 277, 46364-46373.
48. Yoshiura, K., Kanai, Y., Ochiai, A., Shimoyama, Y., Sugimura, T. and Hirohashi, S. (1995). Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. USA 92, 7416-7419.
49. Zajchowski, D. A., Bartholdi, M. F., Gong, Y., Webster, L., Liu, H. L., Munishkin, A., Beauheim, C., Harvey, S., Ethier, S. P. and Johnson, P. H. (2001). Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res. 61, 5168-5178.